Neuroscience
Australian man uses brain implant to send texts from his iPad
The Stentrode — a brain-computer interface implanted through minimally invasive surgery — has been used to send text messages from an iPad
“Laughing gas” may offer quick, long-lasting relief from depression
With ketamine showing potential as an antidepressant, researchers investigate another anesthetic: nitrous oxide, or "laughing gas."
New study will put the leading theory about Alzheimer’s to the test
Washington University in St. Louis is embarking on a drug trial that may also put the amyloid hypothesis to its ultimate test.
“Freakonomics” study offers simple strategy for making tough decisions
People who chose change over inaction, regardless of the decision, self-reported being better off and happier after six months.
It’s time to change how we think about electroshock therapy
Electroconvulsive therapy is more effective than ketamine at treating severe depression, according to a new meta-analysis.
Withdrawal symptoms from antidepressants can last over a year
A scientific review found that withdrawal symptoms from antidepressants and antipsychotics can last for over a year.
Deep brain stimulation can be life-altering for OCD sufferers when other treatment options fall short
Deep brain stimulation relies on thin electrodes implanted deep in the brain that deliver electrical currents. Could it treat OCD?
It may be possible to treat inherited blindness, even in adults
A new mouse study suggests that synthetic retinoids may be able to help restore vision in adults with Leber congenital amaurosis.
Three reasons “you” won’t return after this life
Entire religions are constructed around theories of an afterlife, but former monk Stephen Batchelor lists three reasons you won't come back.
Scientists claim “never before” seen results in ALS clinical trial
The ability of tofersen, a gene-based treatment for ALS, to improve symptoms is being hailed as a “treatment milestone.”